Pioneering generative biology to create breakthrough therapeutics.
201 - 500
π° $370M Series B on 2021-11
Yesterday
201 - 500
Oversee Phase 1-3 trials for next-gen biologics at Generate:Biomedicines. Join a transformative therapeutics company.
πΊπΈ United States β Remote
π° $370M Series B on 2021-11
β° Full Time
π Senior
π Director
π½ H1B Visa Sponsor